Catalyst Wire Dossier Catalyst Wire Dossier

PRO-174

· Laboratorios Sophia S.A de C.V.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PRO-174, covering 2019-10-25 to 2019-10-25. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Tolerability of the PRO-174 Versus Sophixín Ofteno®, on the Ocular Surface of Healthy Subjects [Phase 1]

See pricing